Thursday, August 10, 2017 4:41:03 AM
Quidel is at a three year high with a pps (price per share) of 34.12
Quidel announced that they have entered into a definitive agreement to acquire Alere Triages' Assets
Made ~$118,189,000 in Gross Profits
The Global Biotechnical Market was valued at $270.5 Billion in 2013
Analysts gave QDEL an average estimate of ~$241.32 million for the expected total revenue in 2018.
Quidel Corporation (QDEL) is a biotechnical company that develops, manufactures, and markets their diagnostic testing solutions for infectious diseases, women's' health products, and gastrointestinal diseases. From their research and development efforts, Quidel has a wide range of products to offer. To begin with, they just received FDA Clearance and CLIA waiver for their award winning point-of-car Sofia 2 Instrument which is used for the rapid detection of respiratory syncytial virus (RSB). Also, the company has recently also gotten FDA Clearance to market their Solana C. difficile Assay for the detection of Clostridium difficile-infection (CDI). Their other products include QuickVue influenza, QuickVue RSV, Quidel Molecular RXV, and much more.
On July 17, 2017, Quidel announced that they have entered into a definitive agreement to acquire Alere Triages' Assets. This will allow Quidel to distribute the Triage MeterPro products and BNP assays which brought the acquired company $197 million in revenue for 2016. This comes two months after Quidel completed an acquisition of InflammaDry(R) and AdenoPlus(R) Eye-Health Businesses. With Quidel acquiring so many companies, it is clear that the company is growing into a major player in the biotechnical market.
QDEL is on a clear upward trend following these news releases with no end in sight. Currently, QDEL is at a three year high with a pps (price per share) of 34.12. From 10/13/14, QDEL hit its high at the time of ~28.6 and then fell to its three year low of 14.16 on 2/15/16. From that date forward, the stock has enjoyed many volatile increases upward. With QDEL shattering its previous highest resistance line, the sky is currently the limit for this stock. With a gold cross spotted, QDEL is certainly enjoying a very bullish market.
Read More Here
Recent QDEL News
- The Gross Law Firm Notifies Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 05/14/2024 09:45:00 AM
- Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact The Gross Law Firm Before June 11, 2024 to Discuss Your Rights - QDEL • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:07:08 PM
- QuidelOrtho Reports First Quarter 2024 Financial Results • Business Wire • 05/08/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:14:37 PM
- Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) should contact The Gross Law Firm about pending Class Action - QDEL • PR Newswire (US) • 05/07/2024 10:05:00 AM
- Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 05/03/2024 09:45:00 AM
- QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer • Business Wire • 05/02/2024 12:00:00 PM
- QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - QDEL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) - June 11, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/19/2024 10:40:00 AM
- QuidelOrtho To Report First Quarter 2024 Financial Results • Business Wire • 04/17/2024 11:00:00 AM
- QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay • Business Wire • 04/10/2024 11:00:00 AM
- QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test • Business Wire • 04/02/2024 01:00:00 PM
- QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada • Business Wire • 03/06/2024 09:35:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/29/2024 09:40:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 08:29:59 PM
- QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference • Business Wire • 02/26/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:30:20 PM
- QuidelOrtho Announces Changes in Executive Leadership • Business Wire • 02/21/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:08:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:07:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 12:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:07:22 PM
- QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results • Business Wire • 02/13/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:44:54 AM
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM